Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hematological Parameters Extended for Automated Analyzer

By LabMedica International staff writers
Posted on 20 Jul 2011
The quantification of the percentages of microcytic and hypochromic erythrocytes has proved clinically useful in the differential diagnosis of anemia. More...


Based on classical hematological parameters, subjects with iron deficiency anemia (IDA) are inappropriately differentiated from subjects with anemia owing to thalassemia or chronic disease.

A study conducted at the Hospital Galdakao-Usansolo, (Galdakao, Spain), aimed to establish characteristic analytical features, including the new erythrocyte and reticulocyte parameters, in case of thalassemia trait and IDA. The study population included 90 healthy individuals, 136 β-thalassemia carriers, 121 with mild IDA, and 126 with severe IDA. The scientists used the Sysmex XE 5000, which utilizes the flow fluorescence-cytometry technology, enables independent measurement of the volume and hemoglobin (Hb) content of individual red cells (RBC). Derived from this technology, four new RBCs extended parameters, erythrocyte subsets, are now reported for this analyzer.

When using the Sysmex XE 5000 analyzer, (Sysmex Corporation, Kobe, Japan; www.sysmex.com), the percentages of erythrocyte subsets can be calculated and the new parameters, such percentage of microcytic red cells (%Micro R) and percentage of macrocytic red cells (%Macro R) can be obtained. In the reticulocyte channel, blood cells are stained by a polymethine dye specific for ribonucleic acid, (RNA) /DNA, and analyzed by flow cytometry using a semiconductor laser. A bidimensional distribution of forward scattered light and fluorescence is presented as a scattergram, indicating mature red cells and reticulocytes. Forward scatter correlates with reticulocyte hemoglobin content (Ret He) and erythrocyte hemoglobin content (RBC He).

The results of the study indicate that although the differences between the three groups of anemic patients were statistically significant, the central 95th percentile ranges showed considerable overlap for most hematological parameters including absolute reticulocyte count. The values obtained for the RBC extended parameters were significantly different in the groups. The %Micro R was more increased in thalassemia (38.6 %) than in the mild IDA (16.5%), and in severe IDA (21.6%). Immature reticulocyte fraction (IRF) mean values in the groups were statistically different as the thalassemia group had an intermediate value of 8.7%, which was between the healthy value of 4.4% and IDA values ranging from 12.9% to 16.7%.

The authors concluded the erythrocytosis and severe microcytosis, together with a high percentage of microcytes and a moderate increase in IRF, is the profile of β-thalassemia carriers, whereas anisocytosis and the hypochromic subset correlates with the severity of the anemia in iron-deficient patients. The study was published online on May 12, 2011, in Journal of Clinical Laboratory Analysis.

Related Links:

Hospital Galdakao-Usansolo
Sysmex Corporation



New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Steam Sterilizer
Hi Vac II Line
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.